The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy

A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp

(2011) S.R. Wiegell et al.   BRITISH JOURNAL OF DERMATOLOGY

Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses

(2010) Patrick Gholam et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Pain associated with aminolevulinic acid-photodynamic therapy of skin disease

(2009) Christine B. Warren et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses

(2009) LR Braathen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities

(2009) E Sotiriou et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate

(2008) S.R. Wiegell et al.   BRITISH JOURNAL OF DERMATOLOGY

Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study

(2008) S.R. Wiegell et al.   BRITISH JOURNAL OF DERMATOLOGY

Irradiance-Dependent Photobleaching and Pain in  -Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas

(2008) W. J. Cottrell et al.   CLINICAL CANCER RESEARCH